| 000 | 01337 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513115733.0 | ||
| 264 | 0 | _c19970520 | |
| 008 | 199705s 0 0 eng d | ||
| 022 | _a0030-2414 | ||
| 024 | 7 |
_a10.1159/000227693 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLein, M | |
| 245 | 0 | 0 |
_aSoluble CD44 variants in the serum of patients with urological malignancies. _h[electronic resource] |
| 260 |
_bOncology _c |
||
| 300 |
_a226-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _ximmunology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyaluronan Receptors _xblood |
| 650 | 0 | 4 |
_aKidney Neoplasms _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _ximmunology |
| 650 | 0 | 4 |
_aProstatic Neoplasms _ximmunology |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _ximmunology |
| 700 | 1 | _aJung, K | |
| 700 | 1 | _aWeiss, S | |
| 700 | 1 | _aSchnorr, D | |
| 700 | 1 | _aLoening, S A | |
| 773 | 0 |
_tOncology _gvol. 54 _gno. 3 _gp. 226-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000227693 _zAvailable from publisher's website |
| 999 |
_c9124809 _d9124809 |
||